NYSE - Delayed Quote
USD
Baxter International Inc. (BAX)
25.83
+0.26
(+1.02%)
At close: September 4 at 4:00:03 PM EDT
25.87
+0.04
(+0.15%)
After hours: September 4 at 7:55:05 PM EDT
Trade BAX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for BAX
What's happening with BAX?
Powered by Yahoo ScoutBaxter International is navigating a significant transition with a new CFO and a restructuring strategy, alongside recent positive earnings results that have led to raised guidance. However, concerns linger about revenue growth and regulatory challenges.
Powered by Yahoo Scout
- Previous Close
25.57 - Open
25.33 - Bid 25.88 x 90000
- Ask 25.96 x 100000
- Day's Range
25.28 - 26.11 - 52 Week Range
15.73 - 30.00 - Volume
3,414,998 - Avg. Volume
6,512,317 - Market Cap (intraday)
13.354B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-1.88 - Earnings Date (est.) Oct 29, 2026
- Forward Dividend & Yield 0.04 (0.15%)
- Ex-Dividend Date Aug 28, 2026
- 1y Target Est
28.73
Recent News
View More
Performance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
BAX
35.35%
S&P 500 (^GSPC)
12.75%
1-Year Return
BAX
9.75%
S&P 500 (^GSPC)
18.71%
3-Year Return
BAX
32.73%
S&P 500 (^GSPC)
70.93%
5-Year Return
BAX
65.55%
S&P 500 (^GSPC)
70.18%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/3/2026
-
Market Cap
13.22B
-
Enterprise Value
20.74B
-
Trailing P/E
--
-
Forward P/E
12.50
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.15
-
Price/Book (mrq)
2.13
-
Enterprise Value/Revenue
1.81
-
Enterprise Value/EBITDA
27.21
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-9.27%
-
Return on Assets (ttm)
2.85%
-
Return on Equity (ttm)
-14.37%
-
Revenue (ttm)
11.47B
-
Net Income Avi to Common (ttm)
-968M
-
Diluted EPS (ttm)
-1.88
Balance Sheet and Cash Flow
-
Total Cash (mrq)
2.15B
-
Total Debt/Equity (mrq)
156.45%
-
Levered Free Cash Flow (ttm)
1B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
184.74
-1.54%
Mkt Cap
50.321B
Industry
Medical Instruments & Supplies
339.97
-0.81%
Mkt Cap
23.926B
Industry
Medical Instruments & Supplies
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
The major indices are mixed at midday, but the mood is generally upbeat
The major indices are mixed at midday, but the mood is generally upbeat following the release of additional tame inflation data this morning (this time in the form of wholesale prices). Earnings continue to hit the tape and individual stocks are responding in kind. Crude oil is at $82 per barrel. The yield on the 10-year note is at 4.63%.
-
Executing on turnaround strategy.
Based in Deerfield, Illinois, Baxter International provides critical care, nutrition, renal, hospital, and surgical products. The company has approximately 37,500 employees. BAX shares are a component of the S&P 500.
RatingPrice Target -
Baxter Earnings: 2026 Outlook and Shares Rise on Revenue Growth Acceleration and Tariff Refund
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
RatingPrice Target -
Baxter Earnings: 2026 Outlook and Shares Rise on Revenue Growth Acceleration and Tariff Refund
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
RatingPrice Target
